论文部分内容阅读
目的总结肝细胞癌(HCC)合并肝动脉门静脉分流(APS)、肝动脉肝静脉分流(AVS)的发生率,并探讨影响HCC APS形成的相关因素。方法回顾分析2009年1月-2010年12月经动脉栓塞(TAE)治疗的.497例HCC患者的影像学和病历资料,总结APS、AVS的发生率,采用单因素分析APS的发生与HCC患者性别、年龄、乙型肝炎病史、肝硬化基础、肝癌切除史、甲胎蛋白(AFP)、肿瘤类型、肿瘤数目和门静脉癌栓(PVTT)的相关性,并行多因素Logistic回归分析。结果HCC合并APS的发生率为10.5%(52/497),合并AVS的发生率为1.6%(8/497),同时合并APS与AVS的有3例(0.6%)。单因素分析显示:乙型肝炎病史、肝硬化基础、肿瘤类型、肿瘤数目和门静脉癌栓与HCC患者APS的发生相关;多因素Logistic回归分析显示:肝硬化基础、巨块型肿瘤、肿瘤多发、门静脉癌栓是HCC合并APS发生的危险因素。结论HCC患者有肝硬化基础、巨块型肿块、多发肿瘤、门静脉癌栓会诱发APS的发生
Objective To summarize the incidence of hepatic arterial portal vein shunt (APS) and hepatic artery hepatic vein shunt (AVS) in patients with hepatocellular carcinoma (HCC) and to explore the related factors that affect the formation of APS in HCC. Methods The data of 497 cases of HCC treated with arterial embolism (TAE) from January 2009 to December 2010 were analyzed retrospectively. The incidence of APS and AVS was summarized. The incidence of APS and the gender of HCC were analyzed by univariate analysis , Age, the history of hepatitis B, the basis of liver cirrhosis, the history of liver cancer resection, AFP, tumor type, tumor number and PVTT. Results The incidence of HCC complicated with APS was 10.5% (52/497). The incidence of complicated AVS was 1.6% (8/497). There were 3 cases (0.6%) with APS and AVS. Univariate analysis showed that the history of hepatitis B, the basis of liver cirrhosis, the type of tumor, the number of tumors and portal vein tumor thrombus were related to the occurrence of APS in HCC patients. Multivariate logistic regression analysis showed that the basis of liver cirrhosis, massive tumor, Portal vein tumor thrombus is a risk factor for HCC with APS. Conclusion HCC patients have the basis of liver cirrhosis, massive lumps, multiple tumors, and portal vein tumor thrombus can induce the occurrence of APS